News

Updated Source Data Verification and Lab Normal Values

march 2026

We are pleased to announce the release of ALEA 18.9. This update brings significant enhancements to the Source Data Verification (SDV) feature, including improved performance, greater stability, and expanded functionality for SDV setup.

In addition, updates have been made to our Labs and Lab Normal Values features, further strengthening data management and usability.

These improvements reflect our ongoing commitment to delivering a more efficient and reliable user experience.

ALEA 18.8 released

september 2025

ALEA 18.8 has been released, WHODrug feature expanded, and medical coding for MedDRA now fully implemented into ALEA.

MedDRA medical coding is now supported in ALEA v18.8. MedDRA is an international medical terminology dictionary that can be used for regulatory communication and evaluation of data. MedDRA integration with ALEA allows users to link form data to terminology in MedDRA.

WHODrug medical coding features have been expanded in ALEA v18.8. Changes have been made to synchronize the system better with the newly introduced MedDRA medial coding. Additionally, WHODrug Koda support has been implemented, allowing users to perform automatic coding.

Alea WHODrug implementation validated and approved by Uppsala Monitoring Centre

march 2024

Last week Alea was validated and approved within the WHODrug Vendor Programme for handling C3 format WHODrug data.
The approval within the WHODrug Vendor Programme by the Upsala Monitoring Centre ensures the correct implementation and handling of WHODrug Global data within Alea and related services.

#WHODrug

SAS Hackathon started – Alea providing video assessment tools

march 2021

#hackinSAS officially started! This #hackathon is all about creating a potentially viable product using #analytics to build a better world.

In partnership with Amsterdam UMC, Amsterdam Skills Centre (ASC), Gelre ziekenhuizen and FormsVision BV, #ITsPeople will be developing an automatic classification of the quality of a Laparoscopic Cholecystectomy (gallbladder surgery) based on video’s by deep learning. This #innovation can further enhance the quality of surgery and will contribute to the development of training programs.

ALEA participating in next generation clinical trial design: Cancer Core Europe’s design and development of data rich, dynamic studies in oncology (CCE_DART)

February 2021

Incorporating experts from the seven European comprehensive cancer centers belonging to the Cancer Core Europe (CCE) Consortium, along with an additional four non-CCE partners*, the EU-funded, multi-site project CCE Building Data Rich Clinical Trials (CCE-DART), has now launched.

Coordinated by VHIO’s Elena Garralda, CCE-DART seeks to become a groundbreaking example in driving a novel generation of clinical trials in the current era of precision oncology.

This pioneering project will develop interconnected tools to reduce the current complexity of investigator-initiated trials and better guide clinical decision-making by incorporating cutting-edge digital technologies and platforms.

Cancer Core Europe (CCE) Consortium Members:
– Vall d’Hebron Institute of Oncology, Barcelona, Spain.
– Karolinska Institute, Stockholm, Sweden.
– Cambridge Cancer Center, Cambridge, UK.
– National Center for Tumor Diseases, Heidelberg, Germany.
– Netherlands Cancer Institute, Amsterdam, The Netherlands.
– National Cancer Institute of Milan, Italy.
– Gustave Roussy Cancer Campus Grand Paris, Villejuif, France.

Non-CCE Members:
– Digital Experimental Cancer Medicine Team, Manchester, UK.
– The Hyve, Utrecht, The Netherlands.
– DataRiver, Modena, Italy.
– FormsVision, Abcoude, The Netherlands.

Edge Conference 2019

March 2019

ALEA Clinical is heading back to Birmingham for the next EDGE conference. Last year was a success and we are looking forward to meeting a lot of new people this year. 

The EDGE International Conference – CONNECTED will take place on the 3rd and 4th April 2019 in Birmingham. The 2-day conference will focus on transferring new EDGE skills and practices to improve the efficiency of clinical research. With an extended emphasis on networking and collaboration, CONNECTED will entail greater opportunities to network and make lasting professional contacts. FormsVision / ALEA Clinical can be found during the conference on the Clinical Informatics Research Unit stand.

ALEA scan integration

August 2018 

One of ALEA’s prestigious functionalities is the scan integration. The DICOM viewer can be used in many different scenario’s, for example in the COLORIII Trial of the VUmc Amsterdam, the Netherlands. 

See here what the study is about and how the scans helps in their randomized clinical trial comparing transanal and traditional laparoscopic TME for rectal cancer: https://bit.ly/2Im8BfN

Quality of life questionnaire

June 2018

Several studies set-up in ALEA are about the quality of life of patients suffering from diseases. The module that is being used for this is called ePRO.

In the last couple of years, there has been growth in the request of the ePRO module in ALEA. This is an application allowing data entry by a patient rather than a clinician, e.g. patient diaries and quality of life questionnaires.

Using a quality of life questionnaire gives accurate patient information during the studies. But also after the treatments, the data gathered from the quality of life questionnaires can provide a complete insight in the patients mental and psychical health.

Escrow certificate

April 2018 

Since the 5th of April 2018, ALEA Clinical is officially a escrow certified organisation. This certificate, handed out by Softwareborg, is concluded to ensure and secure the use of ALEA Clinical licensees.

At the 5th of April 2018, Emile van der Donk, CEO of ALEA Clinical signed the arrangement. Therefore we provide an escrow arrangement to interested licensees of ALEA Clinical.

An escrow agreement is a financial arrangement where a third party, in this case the company Softwareborg, holds and regulates payment of the funds required for our customer and ALEA Clinical.

EDGE International Conference 2018: ASPIRE

March 2018

At the end of February, a great conference was organized by EDGE to bring together the members of the research community, allowing to share knowledge and best practice with the aim to enhance clinical research across the UK, Europe, Canada and beyond.

One of the invited keynote speakers was Emile van der Donk, CEO of ALEA Clinical. Emile presented ALEA where randomisation, eCRF and Drug Supply Management that come together in a single, affordable solution.

General Data Protection Regulation

Januari 2018 

It is very likely that you heard about the legislation of the European Union’s General Data Protection Regulation (GDPR), which will be effective from 25th MAY 2018. We as provider of ALEA Clinical software offer a new version ALEA 18.1 which is GDPR compliant. An upgrade to this version cost less and we offer a migration path from the current version that our clients use to the newest version of ALEA. 

The GDPR replaces an older data protection directive and it carries provisions that require businesses and public entities to protect the personal data and privacy recorded. We from ALEA Clinical guide our customers trough the path where the software and agreements will be ‘GDPR proof’. Interested? Please don’t hesitate to contact us via the contact form. 

Safety first, also at ALEA Clinical

November 2017 

You can not always protect your employees, but since 18th November we can at least take care of the safety of our employees in the office. After following a course, almost the whole ALEA Clinical team is ‘In-house emergency service’ certified. Besides the fact that every company should have at least one person with this certificate for safety reasons, ALEA Clinical thought it would be good to always have several persons able to help in risky situations. And also, the whole team learned a lot about reanimation, first aid and putting out a fire.